Dr Reddy's US R&D lab is located in...?

Wrong! Try again.

Wrong!
The correct answer is 1998.
Ranbaxy Laboratories Limited entered the US generic pharmaceutical market in 1994 with the filing of five ANDAs (Abbreviated New Drug Applications) for Cefaclor and, upon approval from the US Food and Drug Administration in 1997, introduced the product under its own label, Ranbaxy Pharmaceuticals Inc in January 1998. Besides anti-infective products, RPI also produces quality anti-expectorants, gastrointestinal products, cardiovasculars, NSAIDs, analgesics, and CNS products. Generic products are manufactured as capsules, tablets and suspensions, and are manufactured at FDA approved plants. Today, RPI has 43 products and over 129 SKUs (Stock Keeping Units).

Correct!
Ranbaxy Laboratories Limited entered the US generic pharmaceutical market in 1994 with the filing of five ANDAs (Abbreviated New Drug Applications) for Cefaclor and, upon approval from the US Food and Drug Administration in 1997, introduced the product under its own label, Ranbaxy Pharmaceuticals Inc in January 1998. Besides anti-infective products, RPI also produces quality anti-expectorants, gastrointestinal products, cardiovasculars, NSAIDs, analgesics, and CNS products. Generic products are manufactured as capsules, tablets and suspensions, and are manufactured at FDA approved plants. Today, RPI has 43 products and over 129 SKUs (Stock Keeping Units).

Wrong! Try again.

Wrong!
The correct answer is Morton Grove Pharma .
Mumbai-based pharma major Cipla has struck a long-term agreement with Morton Grove Pharmaceuticals Inc of Illinois, US, for product launch in the US market. Cipla will develop, manufacture, package and supply a range of prescrip­tion pharmaceutical oral liquid and semi-solid products for MGP. In 1935, Khwaja Abdul Hamied set up The Chemical, Industrial & Pharmaceutical Laboratories, which came to be popularly known as Cipla. On August 17, 1935, Cipla was registered as a public limited company with an authorised capital of Rs 600,000.

Correct!
Mumbai-based pharma major Cipla has struck a long-term agreement with Morton Grove Pharmaceuticals Inc of Illinois, US, for product launch in the US market. Cipla will develop, manufacture, package and supply a range of prescrip­tion pharmaceutical oral liquid and semi-solid products for MGP. In 1935, Khwaja Abdul Hamied set up The Chemical, Industrial & Pharmaceutical Laboratories, which came to be popularly known as Cipla. On August 17, 1935, Cipla was registered as a public limited company with an authorised capital of Rs 600,000.

Wrong! Try again.

Wrong!
The correct answer is Atlanta.
Since its inception in 1984, Dr Reddy's Lab has used cutting-edge technology to discover breakthrough pharmaceutical solutions in therapeutic areas. In a short span, it filed for 64 patents. It was the first Indian company to out-license a molecule for clinical trials to Novo Nordisk – the world leader in diabetes. Dr Reddy's is engaged in basic research, finished dosages, generics, bulk actives, biotechnology and diagnostics. Today it exports bulk actives, branded formulations and generic formulations to over 60 countries. Dr Anji Reddy is the founder chairman of Dr Reddy's Laboratories and is widely recognised as one of the pioneers of the Indian pharmaceutical industry.

Correct!
Since its inception in 1984, Dr Reddy's Lab has used cutting-edge technology to discover breakthrough pharmaceutical solutions in therapeutic areas. In a short span, it filed for 64 patents. It was the first Indian company to out-license a molecule for clinical trials to Novo Nordisk – the world leader in diabetes. Dr Reddy's is engaged in basic research, finished dosages, generics, bulk actives, biotechnology and diagnostics. Today it exports bulk actives, branded formulations and generic formulations to over 60 countries. Dr Anji Reddy is the founder chairman of Dr Reddy's Laboratories and is widely recognised as one of the pioneers of the Indian pharmaceutical industry.

Wrong! Try again.

Wrong!
The correct answer is Neither.
Pfizer's journey in India started off way back in the 50's when a company under the name of Dumex Pvt Ltd was registered on 21st November 1950. The company started basic manufacturing of protein supplement, Protinex and anti-TB drug, Isoniazid in the year 1956. Since 1958, Pfizer products entered India through Dey's Medical Stores and subsequently through Ravisions. Pfizer's pharmaceuticals product portfolio spans a wide range of therapeutic classes from vitamins supplements and nutritionals to antibiotics and cardiovasculars.

Correct!
Pfizer's journey in India started off way back in the 50's when a company under the name of Dumex Pvt Ltd was registered on 21st November 1950. The company started basic manufacturing of protein supplement, Protinex and anti-TB drug, Isoniazid in the year 1956. Since 1958, Pfizer products entered India through Dey's Medical Stores and subsequently through Ravisions. Pfizer's pharmaceuticals product portfolio spans a wide range of therapeutic classes from vitamins supplements and nutritionals to antibiotics and cardiovasculars.

Wrong! Try again.

Wrong!
The correct answer is Cipla, Ranbaxy, Matrix .
In October 2003, Cipla, Ranbaxy and Matrix Laboratories along with Aspen Pharmacare Holdings of South Africa reached an agreement with former American President Bill Clinton's foundation to supply to African and the Caribbean countries HIV/AIDS medicines at highly reduced price. The agreement covers antiretroviral drugs or ARVs, at a highly reduced price of 36-to-38 cents per person per day. At least two million people are expected to receive the medicines by the 2008.

Correct!
In October 2003, Cipla, Ranbaxy and Matrix Laboratories along with Aspen Pharmacare Holdings of South Africa reached an agreement with former American President Bill Clinton's foundation to supply to African and the Caribbean countries HIV/AIDS medicines at highly reduced price. The agreement covers antiretroviral drugs or ARVs, at a highly reduced price of 36-to-38 cents per person per day. At least two million people are expected to receive the medicines by the 2008.